Graphene-modified electrochemical genosensors have demonstrated capabilities for detecting cancer-related DNA mutations such as in BRAF [33], KRAS [34], and EGFR [35] genes in liquid biopsy and patient tissue samples [36]. Here, KRAS is linked to cancer.